Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Industrifonden on the investment in ChromoGenics
Mandate

Vinge advises Industrifonden on the investment in ChromoGenics

October 11, 2007

Industrifonden will invest MSEK 20 in ChromoGenics, a company based in Uppsala that produces an energy saving plastic foil for windows. The new issue of shares also involves the current owners Volvo Technology Transfer and Innovationsbron. The money will be used for the company’s first commercial production plant.

Industrifonden is represented by partner Johan Winnerblad assisted by Johan Larsson.

Related

Vinge has advised Sveafastigheter in connection with its uplisting to Nasdaq Stockholm

 Vinge has advised Sveafastigheter AB (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm. The prospectus was published on 13 June 2025 and the trading on Nasdaq Stockholm commenced on 18 June 2025.
June 18, 2025

Vinge advises Bridgepoint in its acquisition of Safe Life

 Vinge advises Bridgepoint in its agreement to acquire a significant controlling stake in Safe Life, a global leader in the distribution of automated external defibrillators (AEDs), in a transaction that values the company at c. €500 million.
June 16, 2025

Vinge advises Armada Investment AG on its investment in Studsvik

 Armada Investment AG, the Zurich-based entrepreneurial investment firm led by Daniel S. Aegerter, has increased its shareholding in Studsvik to 29.9% of outstanding shares. The investment builds on Armada's initial 9.9% stake acquired in February 2025. The shares of Studsvik are admitted to trading on Nasdaq Stockholm. Armada has invested across the nuclear supply chain for over a decade, with portfolio companies including Oklo, Commonwealth Fusion Systems, Proxima Fusion, Last Energy, and Blykalla.
June 16, 2025